Using a mouse model of atherosclerosis, researchers delivered functional IL-10 mRNA encapsulated in EVs to macrophages, demonstrating a 10% reduction in the size of atherosclerotic plaques as compared to control animals treated with PBS or empty EVs 130. This evidence concerns the gene IL10 and atherosclerosis.